Navigator

      Support By : Li-lab

Drug-Pathway
DRUGs and PATHWAYs
PATHWAY_NAME REACTOME_ID KEGG_ID DRUG_NAME PUBCHEM_CID Datasource
Complement and coagulation cascades R-HSA-114591 map04610 irinotecan 6100671 drug-path
Olfactory transduction R-HSA-9751605 map04740 CP-944629 441335 drug-path
Systemic lupus erythematosus R-HSA-977105 map05322 CP-944629 441335 drug-path
Vascular smooth muscle contraction R-HSA-445355 map04270 CP-944629 441335 drug-path
MAPK signaling pathway R-HSA-9652817 map04010 CP-944629 441335 drug-path
GnRH signaling pathway R-HSA-168638 map04912 CP-944629 441335 drug-path
Graft-versus-host disease R-HSA-1643685 map05332 16-phenyltetranorprostaglandin E2 None drug-path
Neuroactive ligand-receptor interaction R-HSA-5632681 map04080 16-phenyltetranorprostaglandin E2 None drug-path
Olfactory transduction R-HSA-9751605 map04740 16-phenyltetranorprostaglandin E2 None drug-path
Systemic lupus erythematosus R-HSA-977105 map05322 16-phenyltetranorprostaglandin E2 None drug-path
Asthma R-HSA-444620 map05310 16-phenyltetranorprostaglandin E2 None drug-path
Allograft rejection R-HSA-9679028 map05330 16-phenyltetranorprostaglandin E2 None drug-path
Vascular smooth muscle contraction R-HSA-445355 map04270 16-phenyltetranorprostaglandin E2 None drug-path
Type I diabetes mellitus R-HSA-5683209 map04940 16-phenyltetranorprostaglandin E2 None drug-path
Phosphatidylinositol signaling system R-HSA-1280215 map04070 16-phenyltetranorprostaglandin E2 None drug-path
Acute myeloid leukemia R-HSA-9680350 map05221 16-phenyltetranorprostaglandin E2 None drug-path
Endometrial cancer R-HSA-2077421 map05213 16-phenyltetranorprostaglandin E2 None drug-path
GnRH signaling pathway R-HSA-168638 map04912 16-phenyltetranorprostaglandin E2 None drug-path
B cell receptor signaling pathway R-HSA-983705 map04662 trihexyphenidyl 5572 drug-path
Olfactory transduction R-HSA-9751605 map04740 trihexyphenidyl 5572 drug-path